{"transactions":[{"id":1040146,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T20:02:03.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":23100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"shares","element":"transactionShares","label":"F4","text":"This amended Form 4 corrects the number of stock options reported in the original Form 4 filed on September 15, 2025. The original filing incorrectly stated that 23,000 restricted stock units were granted. The correct number of restricted stock units granted was 23,100. Securities beneficially owned changed from 38,666 to 38,766."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amended Form 4 corrects the number of stock options reported in the original Form 4 filed on September 15, 2025. The original filing incorrectly stated that 23,000 restricted stock units were granted. The correct number of restricted stock units granted was 23,100. Securities beneficially owned changed from 38,666 to 38,766."}],"balance_after":38766,"source":{"system":"sec-edgar","filing":"0001683168-25-006986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006986/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-15"}},{"id":1040144,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:29:12.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":38666,"source":{"system":"sec-edgar","filing":"0001683168-25-006957","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006957/ownership.xml","form_type":"4"}},{"id":1114640,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2025-06-11T20:59:45.000Z","date":"2025-06-10","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.4199,"value":6049.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":15666,"source":{"system":"sec-edgar","filing":"0001062993-25-011423","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000106299325011423/form4.xml","form_type":"4"}},{"id":1138722,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2025-05-21T20:13:14.000Z","date":"2025-05-20","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.82,"value":4550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at $1.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":13166,"source":{"system":"sec-edgar","filing":"0001062993-25-009985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000106299325009985/form4.xml","form_type":"4"}},{"id":1408403,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2024-09-12T20:11:23.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001683168-24-006334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824006334/ownership.xml","form_type":"4"}},{"id":1853944,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-06-15T21:00:13.000Z","date":"2023-06-14","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.1,"value":6200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-23-037408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123037408/doc4.xml","form_type":"4"}},{"id":1998892,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-23T00:20:15.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-23-011932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123011932/doc4.xml","form_type":"4"}},{"id":2095615,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-12-05T21:30:23.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":5000,"price":0.4082,"value":2041.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $0.4075 to $0.4089. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-22-059702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122059702/doc4.xml","form_type":"4"}},{"id":2103176,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-11-28T21:30:18.000Z","date":"2022-11-23","kind":"purchase","acquired":true,"shares":2000,"price":0.4099,"value":819.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-22-058862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122058862/doc4.xml","form_type":"4"}},{"id":2391332,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:06:56.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001209191-22-010391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010391/doc4.xml","form_type":"4"}},{"id":2811649,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:17.000Z","date":"2021-03-03","kind":"purchase","acquired":true,"shares":682,"price":3.15,"value":2148.3,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-21-017572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017572/doc4.xml","form_type":"4"}},{"id":2811648,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:17.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":12318,"source":{"system":"sec-edgar","filing":"0001209191-21-017572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017572/doc4.xml","form_type":"4"}},{"id":3363920,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2019-11-21T00:24:07.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":127500,"price":0.1,"value":12750.0,"ownership":{"direct":true},"balance_after":127500,"source":{"system":"sec-edgar","filing":"0001209191-19-057494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119057494/doc4.xml","form_type":"4"}}]}